Last updated on November 2017

RENAL AID: Repository of Novel Analytes Leading to Autoimmune, Inflammatory, and Diabetic Nephropathies


Brief description of study

RENAL AID: Repository of Novel Analytes Leading to Autoimmune, Inflammatory, and Diabetic Nephropathies

Detailed Study Description

The purpose of this research bio-repository study is to collect demographic, clinical, biochemical, histological, and genetic (RNA) data and samples from a large population of subjects with a variety of renal disease states, including diabetic, inflammatory, autoimmune and transplant related renal conditions, in order to assess for factors that may be associated with the progression of disease, the incidence of complications, (including renal failure), and the responses to therapy. In addition, the bio-repository will include the collection of data and samples from control subjects without established renal disease.

This study will provide an opportunity to compare data from various disease states with the objective of determining clinical and biological factors that predict disease progression, response to therapy and identify discriminating non-invasive clinical and biological features that predict renal biopsy findings.

Potential Benefits: There is no guarantee that subjects will benefit personally from this study. Knowledge gained from RENAL AID may benefit subjects and others in the future.

Clinical Study Identifier: TX12398

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Alan Perlman, M.D

The Rogosin Institute
New York, NY USA
  Connect »